CN103860958B - A kind of Chinese medicine composition for treating acne - Google Patents
A kind of Chinese medicine composition for treating acne Download PDFInfo
- Publication number
- CN103860958B CN103860958B CN201410092487.0A CN201410092487A CN103860958B CN 103860958 B CN103860958 B CN 103860958B CN 201410092487 A CN201410092487 A CN 201410092487A CN 103860958 B CN103860958 B CN 103860958B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 206010000496 acne Diseases 0.000 title claims abstract description 50
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 241000628997 Flos Species 0.000 claims abstract description 44
- 210000000582 semen Anatomy 0.000 claims abstract description 22
- 239000009636 Huang Qi Substances 0.000 claims abstract description 21
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 20
- 239000010231 banlangen Substances 0.000 claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 239000002552 dosage form Substances 0.000 claims abstract description 5
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 10
- 238000004321 preservation Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 23
- 231100000614 poison Toxicity 0.000 abstract description 10
- 230000008901 benefit Effects 0.000 abstract description 8
- 239000003440 toxic substance Substances 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000008506 pathogenesis Effects 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000007170 pathology Effects 0.000 abstract description 3
- 239000002574 poison Substances 0.000 abstract description 3
- 239000011805 ball Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 230000002124 endocrine Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 210000003780 hair follicle Anatomy 0.000 description 26
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 12
- 240000007711 Peperomia pellucida Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000008595 infiltration Effects 0.000 description 9
- 238000001764 infiltration Methods 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 210000002615 epidermis Anatomy 0.000 description 8
- 210000001732 sebaceous gland Anatomy 0.000 description 8
- 229960003604 testosterone Drugs 0.000 description 8
- 230000003780 keratinization Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 206010040943 Skin Ulcer Diseases 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 231100000019 skin ulcer Toxicity 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 210000004907 gland Anatomy 0.000 description 4
- 210000004969 inflammatory cell Anatomy 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000011280 coal tar Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000003325 follicular Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 210000003859 smegma Anatomy 0.000 description 2
- 238000012109 statistical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- 206010000349 Acanthosis Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000751898 Paederus fuscipes Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010042928 Syringomyelia Diseases 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- -1 chloroxoquinoline Lead Chemical compound 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410092487.0A CN103860958B (en) | 2014-03-13 | 2014-03-13 | A kind of Chinese medicine composition for treating acne |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410092487.0A CN103860958B (en) | 2014-03-13 | 2014-03-13 | A kind of Chinese medicine composition for treating acne |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103860958A CN103860958A (en) | 2014-06-18 |
CN103860958B true CN103860958B (en) | 2016-08-17 |
Family
ID=50900345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410092487.0A Expired - Fee Related CN103860958B (en) | 2014-03-13 | 2014-03-13 | A kind of Chinese medicine composition for treating acne |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103860958B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147198A (en) * | 2014-08-27 | 2014-11-19 | 庄妍 | Traditional Chinese medicine compound for treating papular acne and preparation thereof |
CN104146942A (en) * | 2014-08-29 | 2014-11-19 | 桂林市艾康科技有限公司 | Bamboo liquid facial mask for resisting inflammatory and senescence |
CN104208514A (en) * | 2014-09-16 | 2014-12-17 | 于向英 | Composition for treating hairline sore |
CN105267300A (en) * | 2014-12-26 | 2016-01-27 | 完美(中国)有限公司 | Acne removing traditional Chinese medicine composition |
CN104721349B (en) * | 2015-04-12 | 2017-12-19 | 卫俊斗 | A kind of Xiao Cuo Jie Fu Cream Chinese medicine composition and preparation method thereof |
CN104857078A (en) * | 2015-06-09 | 2015-08-26 | 徐艳 | Medicinal preparation for treating acne |
CN106177635A (en) * | 2016-08-30 | 2016-12-07 | 陈秀华 | A kind of Chinese medicine composition for anti-acne and the application in mask product thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002076479A1 (en) * | 2001-03-27 | 2002-10-03 | Bime Laboratories | Composition for treating acne vulgaris and fabrication method |
CN102114203A (en) * | 2010-05-01 | 2011-07-06 | 胡海舰 | Traditional Chinese medicine composition for treating acnes |
-
2014
- 2014-03-13 CN CN201410092487.0A patent/CN103860958B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103860958A (en) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860958B (en) | A kind of Chinese medicine composition for treating acne | |
CN102106957B (en) | Chinese medicinal composition for treating hyperlipidemia | |
CN103520572B (en) | A kind of Chinese medicine composition being used for the treatment of atopic dermatitis and preparation method thereof | |
CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
CN103736036A (en) | Drug for treating nonalcoholic fatty liver disease and preparation method thereof | |
CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
CN101485848B (en) | Decoction for treating eczema and preparation method thereof | |
CN103432412B (en) | Medicament for treating hyperplasia of mammary glands and preparation method thereof | |
CN103341092A (en) | Preparation method of powder for treating atrophic vaginitis | |
CN101239134B (en) | Speckle-removing medicinal composition | |
CN103041028B (en) | Traditional Chinese medicine composition for treating acne | |
CN105106498A (en) | Traditional Chinese medicine composition for treating diabetic foot | |
CN104998158A (en) | Pharmaceutical composition for treating liver cirrhosis and application thereof | |
CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
CN103301373A (en) | Pharmaceutical composition for treating postpartum perineal mucosal lesions | |
CN108434373A (en) | A kind of Chinese medicine composition for treating acne, eczema and butterfly macules | |
CN103341094B (en) | Preparation method of powder for treating vulva squamous epithelial cell hyperplasia | |
CN108042744A (en) | A kind of Chinese medicine composition and preparation method for being used to treat prostatic disorders | |
CN103316270B (en) | Preparation method of powder of medicine for treating postnatal perineum mucosal lesion | |
CN102406913A (en) | Chinese medicinal composition for treating melancholia | |
CN103330896B (en) | Preparation method of powder for treating postpartum nonspecific vaginitis | |
CN102091254A (en) | Traditional Chinese medicine composition for relieving swelling after cosmetic surgery and preparation method thereof | |
CN102671143B (en) | Parslane herb Chinese medicinal oral liquid for treating dysentery and preparation method for parslane herb Chinese medicinal oral liquid | |
CN105943860A (en) | Medicine preparation for treating diabetes mellitus and preparation method thereof | |
CN105688071A (en) | Traditional Chinese medicine for treating interstitial lung disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Tong Haishan Inventor after: Yang Zhili Inventor after: Wang Xiaodong Inventor before: Zhuang Yan |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160720 Address after: 266000 Qingdao City, Sifang District, Shandong flood water ditch village, No. 2, 106 Applicant after: Chen Hong Applicant after: Tong Haishan Address before: 266109, 1, 700 the Great Wall Road, Chengyang District, Shandong, Qingdao Applicant before: Zhuang Yan |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170727 Address after: 274114 No. 422, Chen Cun, Chen Lou administrative village, Huang Zhen Town, Dingtao County, Shandong Province Patentee after: Chen Ergui Address before: 266000 Qingdao City, Sifang District, Shandong flood water ditch village, No. 2, 106 Co-patentee before: Tong Haishan Patentee before: Chen Hong |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160817 Termination date: 20180313 |